# Efficacy and Safety of DIGNICAP™ System

> **NCT03712696** · NA · COMPLETED · sponsor: **European Institute of Oncology** · enrollment: 139 (actual)

## Conditions studied

- Breast Cancer
- Chemotherapy-induced Alopecia

## Interventions

- **DEVICE:** DIGNICAP™

## Key facts

- **NCT ID:** NCT03712696
- **Lead sponsor:** European Institute of Oncology
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07-18
- **Primary completion:** 2018-04-30
- **Final completion:** 2018-09-20
- **Target enrollment:** 139 (ACTUAL)
- **Last updated:** 2018-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03712696

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03712696, "Efficacy and Safety of DIGNICAP™ System". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT03712696. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*